Burdon et al., 1999 - Google Patents
Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cellsBurdon et al., 1999
- Document ID
- 6574669602047483973
- Author
- Burdon T
- Chambers I
- Stracey C
- Niwa H
- Smith A
- Publication year
- Publication venue
- Cells Tissues Organs
External Links
Snippet
An ability to propagate pluripotent embryonic cells in culture is the foundation both for defined germline modification in experimental rodents and for future possibilities for broad- based cellular transplantation therapies in humans. Yet, the molecular basis of the self …
- 230000004069 differentiation 0 title abstract description 28
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burdon et al. | Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells | |
Ware et al. | Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death | |
Metcalf | The unsolved enigmas of leukemia inhibitory factor | |
Burdon et al. | Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells | |
Rathjen et al. | Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors | |
Conover et al. | Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells | |
Qu et al. | A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development | |
Nichols et al. | Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines | |
De Felici et al. | Experimental approaches to the study of primordial germ cell lineage and proliferation | |
Dravid et al. | Defining the role of Wnt/β‐catenin signaling in the survival, proliferation, and self‐renewal of human embryonic stem cells | |
Rossant | Stem cells from the mammalian blastocyst | |
Pesce et al. | Oct-4: lessons of totipotency from embryonic stem cells | |
Chambers et al. | Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells | |
Sheng et al. | Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survivals | |
Larsen et al. | Suppressors of cytokine signalling: SOCS | |
Artus et al. | A role for PDGF signaling in expansion of the extra-embryonic endoderm lineage of the mouse blastocyst | |
Pevny et al. | Development of hematopoietic cells lacking transcription factor GATA-1 | |
Kimura et al. | AKT signaling promotes derivation of embryonic germ cells from primordial germ cells | |
Lacaud et al. | Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro | |
Robertson et al. | A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1 | |
Humphrey et al. | Maintenance of pluripotency in human embryonic stem cells is STAT3 independent | |
Jacques et al. | Fgf8 induces pillar cell fate and regulates cellular patterning in the mammalian cochlea | |
Li et al. | Distinct GATA6-and laminin-dependent mechanisms regulate endodermal and ectodermal embryonic stem cell fates | |
Kristensen et al. | Cytokine signalling in embryonic stem cells | |
Biechele et al. | Porcn-dependent Wnt signaling is not required prior to mouse gastrulation |